BioPharm International, January 2012 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, January 2012
Features
Therapeutic Vaccine Outlook
By Rich Whitworth
Has an approval in oncology reignited interest in the recruitment of the immune system in the fight against disease?
The Conception and Production of Conjugate Vaccines Using Recombinant DNA Technology
By Veronica Gambillara
Recombinant technology can be used to produce conjugate vaccines.
Ice Fog as a Means to Induce Uniform Ice Nucleation During Lyophilization (Peer Reviewed)
By Prerona Chakravarty , Ron Lee , Frank DeMarco , Ernesto Renzi
The authors describe a novel means to control ice nucleation using a sterile cryogenic ice fog.
An Overview of Risk Assessment Strategies for Extractables and Leachables
By Thomas E. Stone
Approaches for risk assessment of extractables and leachables.
A 25-Year Retrospective on Separations Technology
This month, we rewind to "Separations Technology Outlook, Part II: Improved Recovery and Greater Purity."
From the Editor
Here's to a Year of Compromise
By Angie Drakulich
The benefits of harmonization may be on industry's wish list, but buying into change is another story.
Regulatory Beat
Budget Crunch, Political Battles Shape Policy Agenda for Year
By Jill Wechsler
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
Perspectives on Outsourcing
Contract Services in 2012
By Jim Miller
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
Burrill on Biotech
Global Economic Woes Overshadow Biotech Industry Advances in 2011
By G. Steven Burrill
Greater emphasis on focus and efficiency for companies as market demands value in 2012.
Compliance Notes
Auditing by the Numbers
By Susan J. Schniepp
Contract organizations must have highly organized teams and plans to accommodate today's audits.
Final Word
USAID Moves Global Healthcare Initiatives Forward
By Angie Drakulich
Government plans require investment, partnership, and industry collaboration.

ADVERTISEMENT

ADVERTISEMENT

Click here